Original Article
Comparison
of Post-operative Inflammatory Pattern between Intracameral Ceftazidime and
Cefuroxime Used for the Prevention of Post-operative Endophthalmitis
Muhammad Moin, Arooj Amjad, Sameer Nagi
Pak J Ophthalmol 2019, Vol. 35, No. 3
. . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . .. . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . .
See end of article for authors affiliations …..……………………….. Correspondence to: Arooj
Amjad, Assistant
Professor, Postgraduate
Medical Institute, Ameer ud
Din Medical College, Lahore Email: Arooj.amjad@gmail.com |
Purpose: To compare the post operative
inflammatory pattern after phacoemulsification in patients receiving
intra-cameral injection of ceftazidime and cefuroxime per-operatively for the
prevention of post-operative endophthalmitis. Study Design: Quasi experimental study. Place and Duration of
Study: Ophthalmology
Department Unit-1, Lahore General Hospital, Lahore from November 2016 to
March 2018. Material and Methods: Patients undergoing
phacoemulsification with intraocular lens implantation were divided into 2
groups by convenient sampling. Group A received Cefuroxime and group B
received Ceftazidime both as 1 mg/0.1ml intra-cameral injections at the end
of the routine surgery. The patients were examined pre and post operatively
on slit lamp and the number of cells in the anterior chamber (A/C) were
counted on first day, first week and 6 weeks after surgery. Results: Out of 260 patients there were 130
in each group. On the first post-operative day in group A there were grade 1
cells in A/C in 22 patients, grade 2 in 93 patients, grade 3 in 14 patients
and Grade 4 in 1 patient. In group B there were grade 1 cells in A/C in 11
patients, grade 2 in 96 patients, grade 3 in 20 patients and grade 4 in 3
patients. After one week, in group A, cell counts were grade 0 in 27 patients
while in group B, cell counts were grade 0 in 23 patients. After 6 weeks no
patient in any group showed any activity in the anterior chamber. Conclusion: There is little difference in post
operative inflammatory pattern of intracameral ceftazidime antibiotic
prophylaxis as compared to intracameral cefuroxime. Key Words: Endophthalmitis, Cataract Surgery,
Cefuroxime, Ceftazidime. |
Cataract is one of the most common causes of reversible blindness
in the World and cataract surgery is one of the most commonly performed routine
procedures by the ophthalmologists. Although there is a high success rate but
still cataract surgery can lead to serious complications such as
endophthalmitis, which is an inflammatory reaction that occurs as a result of
intraocular colonization by microorganisms such as bacteria, fungi and rarely
parasites. It can either be exogenous in type which can occur post-operatively
or after trauma because of microbial contamination that spreads from the ocular
surface or open wound or through contaminated instruments, intraocular implants
such as lenses (IOLs) or intraocular foreign bodies or it can be endogenous
(septicemia) in origin. Endophthalmitis has a poor visual outcome as shown by
the European Society of Cataract and Refractive Surgeons (ESCRS) study where
17% of the patients had a final visual acuity 20/200 or worse and 48.3% had a
final visual acuity 20/40 or worse1. Furthermore, if it is not
treated it can progress and the inflammation can spread to other intraocular
structures leading to great reduction in quality of life2. It can
cause complete loss of visual acuity and/or loss of the involved eye. According
to the ESCRS study the patients undergoing cataract surgery using a clear
corneal incision were more likely to develop post-operative endophthalmitis by
5.88 times as compared to those in which
scleral incision was used although there were other risk factors such as old
age and wound dehiscence3. There have been many methods described to
prevent post-operative endophthalmitis. One of the most commonly used methods
to prevent the infection was prophylactic instillation of 5% povidone–iodine or
topical antibiotic drops into the conjunctival sac per-operatively4.
One study described that per-operative injection of antibiotics in the anterior
chamber (intra-cameral) might be able to eliminate the bacteria that got access
to the anterior chamber. In this regard, the antibiotics could either be given
as continuous infusion during the surgery along with the irrigating BSS (basic
salt solution) as a variable dose5 or at the end of surgery as a
fixed dose bolus injection. A UK based study compared the efficacy of
subconjunctival antibiotic injection and intracameral antibiotic injection6
for the prevention of post-operative endophthalmitis concluding that the
intracameral injections were more effective than subconjunctival injections.
Many studies compared different antibiotics to be given as an intracameral
injection at the end of surgery for the same purpose. In a retrospective study
and some prospective trials, cephalosporins and vancomycin were studied
extensively and evidence was provided on clinical efficacy of intracameral
cephalosporins7. In this regard, the drug that proved to be very
effective in reduction of the risk for acute onset of post-operative
endophthalmitis was intracameral cefuroxime8. These studies however,
did not compare the efficacy and safety of cephalosporins other than
cefuroxime. This limitation was addressed by another study which compared
cefuroxime, cefazolin and ceftazidime and their safety profiles for
intracameral use9. Apparently, 1 mg intracameral injection of
cefuroxime effectively inhibited all the sensitive bacterial strains and
therefore, it was associated with a low incidence of postoperative
endophthalmitis. Cefuroxime was chosen on the basis of a Swedish study which
comprised of a series of endophthalmitis cases from the year 1996 to the year
2000. Moreover, a third-generation cephalosporin, ceftazidime was also used in
Sweden following an epidemic that was caused by a Gram-negative bacterial strain.
Another study showed the availability of intracameral antibiotics according to
spectrum of activity, pharmacology, preparation, dosage as well as their safety
and efficacy10.
The rationale of our study was
to consider more alternatives to cefuroxime for the treatment of post-operative
endophthalmitis. Although cefuroxime is used on regular basis, it has been less
available in areas where it is not produced locally with pharmaceutical
companies discontinuing its production abroad. Ceftazidime being its potential
substitute could therefore be used. The purpose of this study was to compare
the post operative inflammatory pattern after phacoemulsification in patients
receiving intra-cameral injection of ceftazidime and cefuroxime per-operatively
for the prevention of post-operative endophthalmitis.
MATERIAL &
METHODS
Patients undergoing cataract
surgery in the Ophthalmology Department of Lahore General Hospital, Lahore were
selected by convenient sampling to receive prophylactic intracameral injections
of antibiotics towards the end of routine cataract surgery. The patients
included in this study were adult patients who presented in Ophthalmology
Department of Lahore General Hospital from November 2016 to March 2018. The
patients with history of previous trauma, uveitis, corneal disease, glaucoma
and complicated cataract were excluded from the study. Patients with only eye
and/or those with history of endophthalmitis in the other eye were also not
included. These patients were divided into two groups. In group A, the patients
received Cefuroxime whereas those in group B received Ceftazidime both as 1
mg/0.1ml intracameral injections at the end of the surgery after wound
hydration and before chamber formation. Approval was taken from the hospital
Ethical Review Committee. The patients were examined pre and post operatively
on slit lamp prior to pupillary dilatation on the slit lamp (Haag Streit, BQ
900). Post operative inflammation was graded according to the number of
anterior chamber cells in a 1 mm by 1 mm slit beam field using 16 times
magnification as anterior chamber cells are a dispensable indicator of
inflammatory activity. This was done according to SUN (Standardization of
Uveitis Nomenclature) working group grading of the anterior chamber cells11
as shown in table 1. Follow up examinations were done on day 1, week 1 and week
6 after surgery. The data was recorded on an electronic medical database and
later on analyzed by using SPSS 20.0. Comparison of the
Table 1: Grading of anterior chamber cells (1 mm by 1 mm slit beam)
according to SUN11.
Grade |
Cells in field |
0 |
< 1 |
1+ |
6 – 15 |
2+ |
16 – 25 |
3+ |
26 – 50 |
4+ |
> 50 |
two groups was done using Chi square test and p
value equal to or less than 0.05 was taken as significant.
RESULTS
Out of total 260 patients, 130 were allocated to each group. The
first post-operative day results showed mostly mild to moderate inflammation
(grade 1 and 2) in both groups. After 1st post operative week there
was mostly none to mild inflammation (grade 0 and 1) in both groups. On last
follow up at 6 weeks there was no inflammation (grade 0) in both groups (table
2).
While performing Pearson Chi
square tests for independence on day 1 and week 1 the values were high on chi
square test statistics (5.773 and 3.540) indicating that there is very little
if no relationship between the antibiotics used (table 3). Furthermore, none of the patients developed
endophthalmitis.
Table 2: Results on first day, first
week and 6 weeks after surgery.
Antibiotic |
Cells in Anterior Chamber 1st Day Post-op |
Total |
P value |
||||
Grade 0 |
Grade 1 |
Grade 2 |
Grade 3 |
Grade 4 |
|||
(Group A) Cefuroxime (Group B) Ceftazidime Total |
0 0 0 |
22 (17%) 11 (8 %) 33 |
93 (71%) 96 (74%) 189 |
14 (11%) 20 (16%) 34 |
1 (1%) 3 (2%) 4 |
130 130 260 |
.123 |
|
Cells in Anterior Chamber 1st Week Post-op |
Total |
P value |
||||
Grade 0 |
Grade 1 |
Grade 2 |
Grade 3 |
Grade 4 |
|||
(Group A) Cefuroxime (Group B) Ceftazidime Total |
27 (21%) 23 (18%) 50 |
100 (76.5%) 102 (78.5%) 202 |
2 (1.5%) 3 (2%) 5 |
0 (0%) 2 (1.5%) 2 |
1 (1%) 0 (0%) 1 |
130 130 260 |
.472 |
|
Cells in Anterior Chamber 6 week Post-op |
Total |
P value |
||||
Grade 0 |
Grade 1 |
Grade 2 |
Grade 3 |
Grade 4 |
|||
(Group A) Cefuroxime (Group B) Ceftazidime Total |
130 (100%) 130 (100%) 260 |
0 0 0 |
0 0 0 |
0 0 0 |
0 0 0 |
130 130 260 |
.472 |
Table 3: Statistical Analysis using
Chi Square test for day 1 and week 1.
Statistical
Analysis |
Analysis for
Day 1 |
Analysis for
Week 1 |
||||
Value |
Df |
Asymp. Sig.
(2-sided) |
Value |
Df |
Asymp. Sig.
(2-sided) |
|
Pearson Chi-Square Likelihood Ratio Linear by Linear Association No. of Valid Cases |
5.773 5.896 5.313 260 |
3 3 1 |
.123 .117 .021 |
3.540 4.700 .000 260 |
4 4 1 |
.472 .319 1.00 |
DISCUSSION
Post-operative endophthalmitis (POE) after cataract surgery is a
dangerous and vision-threatening yet uncommon complication that is reported to
occur at approximate rates ranging from 0.03% to 0.2%. The most critical steps
for minimizing the incidence of visual loss due to endophthalmitis are prompt
diagnosis and early treatment. However, most recently all the efforts have been
focused on the administration of antibiotics prophylactically so as to prevent
the development of endophthalmitis12. For prevention of this serious
complication many methods have been tried and tested from instillation of 5%
povidone iodine in the eye pre-operatively to subconjunctival and intra-cameral
antibiotic injections at the end of surgery. Among these methods, intracameral
injection of cephalosporins has been under limelight for the past two decades.
According to a survey conducted in Pakistan in 2005 only 1.87 percent of the
consultants used intracameral antibiotic injections prophylactically for the
prevention of post-operative endophthalmitis13. In our study, we
have compared the efficacy of two commonly used intracameral cephalosporins;
Cefuroxime and Ceftazidime. Due to non-availability of intracameral
preparations of cephalosporins on a commercial level, we had to reconstitute
the injection from the readily available powder form provided for either
intravenous or intramuscular injections. For this purpose the manufacturers of
these drugs recommended the use of distilled water. We used normal saline to
reconstitute the solutions for intracameral use so as to avoid hypo-tonicity,
as in the majority of clinical studies. Gupta et al used balanced salt solution
as control14. Lockington et al however, gave a comparison of two
protocols for dilution of cefuroxime injection13. They concluded
that errors were bound to arise with usage of small (1cc) syringes. In our
study, we used preparations that were reconstituted from 1 gram ceftazidime
vials and 750 milligrams cefuroxime vials. We used 10 cc syringes for this
purpose, ensuring complete dissolution of the powdered drug and accuracy of
dose. Errors in drug dilution and dose calculation may lead to increased risk
of toxic anterior chamber syndrome. The reconstituted cephalosporin solutions
were discarded after 4 hours of preparation so as to avoid any possible loss of
efficacy. After all these measures, we injected intracameral cefuroxime in
Group A patients and ceftazidime in Group B patients. We then measured cells in
their anterior chambers on Day 1, week 1 and week 6 post-operatively. There was
no statistically significant difference in the efficacy of both drugs. However,
just like Barry et al this study only counted number of anterior chamber cells,
not taking other diagnostic criteria for both acute and chronic endophthalmitis
and other potential measurable features into account15. Also, in our
study the absolute endothelial cell loss was not measured as Montan et al did
in their study which was done on the safety of intracameral cefuroxime10.
Some large case series and randomized clinical trials showed the
safety and efficacy of prophylactic use of intracameral cephalosporin
injections for prevention of post-operative endophthalmitis following cataract
surgery. According to the results from European Society of Cataract and
Refractive Surgeons (ESCRS) multicenter randomized control trial which was done
on 16,211 patients, the risk of development of endophthalmitis could be fairly
reduced by 4.9-fold with use of a prophylactic intracameral injection of
cefuroxime16. Another analysis comparing the efficacy and safety of
different antibiotic groups has shown that intracameral injections of
Moxifloxacin and Cefuroxime reduce the rate of occurrence of endophthalmitis as
compared to the controls with minimal or no toxicity events at the standard
routine doses17. According to a ten year comparative study also,
intracameral cefuroxime has proven to be very effective in reduction of risk
for acute-onset endophthalmitis after cataract surgery18. Another
study concluded that 1 mg intracameral injection of cefuroxime apparently
inhibited all the sensitive bacterial strains effectively and was also
associated with a low incidence of postoperative endophthalmitis19.
Seal et al concluded that the risk of contracting endophthalmitis after
cataract removal by phacoemulsification was fivefold decreased by per-op
intracameral injection of cefuroxime20. The p values were given as
0.001 for presumed endophthalmitis and 0.005 for proven endophthalmitis. A
German study also gave results that supported the significantly effective role
of intracameral injection of cefuroxime in reduction of the rate of
postoperative infectious endophthalmitis after cataract surgery21.
The economic evaluation also compared many different prophylaxis regimens and
drew the inference that intracameral cefuroxime has proved to be the best when
it comes to cost-effectiveness22.
However, we needed an effective substitute of Cefuroxime because
of its non-availability in areas where it is not produced locally with
international pharmaceutical companies discontinuing distribution locally.
Therefore, in our study we compared the effect of intracameral cefuroxime
injection with intracameral ceftazidime injection and found that both produced
similar post operative inflammatory patterns and endophthalmitis was not seen
in any patient. A randomized control trial on the safety of intracameral
cephalosporins concluded that ceftazidime, cefuroxime and cefazolin all could
be safely used as 1 mg in 0.1 mL prophylactic intracameral injection during
cataract surgery towards the end. In this series, 55 out of 59 strains of
microbial pathogens that were isolated were found sensitive to cefuroxime9.
According to a recent study, the evidence to support intracameral cefuroxime
use for reduction in the rate of acute post-operative endophthalmitis after
cataract surgery is not strong enough. There is however, a marginal benefit
that might be considered to justify its use23. More recently there
have been debates about the use of intracameral antibiotic prophylaxis in every
patient undergoing cataract surgery on routine basis24.
The limitation of our study
was that it was done at one center only and the sample size was small. To get
more generalizable results in the population larger multicenter study needs to
be done. If substantiated by a further research involving many centers our
study may provide further rationale for the use of ceftazidime as compared to
cefuroxime.
CONCLUSION
In summary, we demonstrate
that there is no significant statistical difference between the post operative
inflammatory patterns of both the treatments. They both prevent endophthamitis and
there is little if any difference in
ceftazidime antibiotic prophylaxis compared to the current cefuroxime regimen
used in the patients. This, in turn, can further aid and help in the evaluation
of the safety and effectiveness of the two antibiotics above and beyond just
prevention of a post-operative complication.
Financial
Disclosure
No author has a financial or
proprietary interest in any material or method mentioned.
Conflict of
Interest
None.
REFERENCES
1. Barry P, Gardner S, Seal
D, Gettinby G, Lees F, Peterson M et al. Clinical observations associated
with proven and unproven cases in the ESCRS study of prophylaxis of
postoperative endophthalmitis after cataract surgery. J Cataract Refract
Surgery, 2009; 35 (9): 1523-1531.e1. doi: 10.1016/j.jcrs.2009.03.049. PubMed PMID: 19683148.
2. Clark A, Ng J, Morlet N,
Tropiano E, Mahendran P, Spilsbury K et al. Quality of life after
postoperative endophthalmitis. Clin Exp Ophthalmol, 2008; 36 (6): 526-531. J
Cataract Refract Surg. 2009 Sep;35(9):1523-31, 1531.e1. Doi:
10.1016/j.jcrs.2009.03.049. PubMed PMID: 19683148.
3. Wejde G, Samolov B,
Seregard S, Koranyi G, Montan P. Risk factors for endophthalmitis following
cataract surgery: a retrospective case–control study. J Hosp Infec, 2005; 61
(3): 251-256.
4. Ciulla TA, Starr MB,
Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an
evidence-based update. Ophthalmology, 2002; 109 (1): 13–24.
5. Sobaci G, Tuncer K,
Taş A, Özyurt M, Bayer A, Kutlu U. The effect of intraoperative
antibiotics in irrigating solutions on aqueous humor contamination and
endophthalmitis after phacoemulsification surgery. Eur J Ophthalmol. 2003; 13
(9–10): 773–778.
6. Yu-Wai-Man P, Morgan SJ, Hildreth AJ, Steel DH,
Allen D. Efficacy of intracameral and subconjunctival cefuroxime in
preventing endophthalmitis after cataract surgery. J Cat Refract Surg, 2008; 34
(3): 447-451. doi:
10.1016/j.jcrs.2007.10.041.
7. Romero P, Méndez I,
Salvat M, Fernández J, Almena M. Intracameral cefazolin as prophylaxis
against endophthalmitis in cataract surgery. J Cataract Refract Surg. 2006; 32
(3): 438–441.
8. García-Sáenz MC,
Arias-Puente A, Rodrígeuz-Caravaca G, Bańuelos JB. Effectiveness of
intracameral cefuroxime in preventing endophthalmitis after cataract surgery:
ten-year comparative study. J Cataract Refract Surg. 2010; 36 (2): 203–207.
9. Lam PT, Young AL, Cheng
LL, Tam PM, Lee VY. Randomized controlled trial on the safety of
intracameral cephalosporins in cataract surgery. Clin Ophthalmol. 2010; 4:
1499–1504.
10. Braga-Mele R, Chang DF,
Henderson BA, Mamalis N, Talley-Rostov A, Vasavada A. Intracameral
antibiotics: Safety, efficacy, and preparation. J Cataract Refract Surg. 2014
Dec; 40 (12): 2134-42.
11. Trusko B1, Thorne J, Jabs
D, Belfort R, Dick A, Gangaputra S, Nussenblatt R, Okada A, Rosenbaum J.
The Standardization of Uveitis Nomenclature (SUN) Project. Development of a
clinical evidence base utilizing informatics tools and techniques. Methods Inf
Med. 2013; 52 (3): 259-265.
12. George NK, Stewart MW.
The Routine Use of Intracameral Antibiotics to Prevent Endophthalmitis after
Cataract Surgery: How Good is the Evidence Ophthalmol Ther. 2018 Dec; 7 (2):
233-245.
13. Ashraf KM, Siddique M.
Endophthalmitis prophylaxis for cataract surgery: The first Pakistan survey. J
Cataract Refract Surg. 2006; 32 (2): 368.
14. Gupta MS, McKee HDR,
Saldańa M, Stewart OG. Macular thickness after cataract surgery with
intracameral cefuroxime. J Cataract Refract Surg. 2005; 31 (6): 1163–1166.
15. Barry P, Behrens-Baumann W,
Pleyer U, Seal D. ESCRS Guidelines on prevention, investigation and
management of post-operative endophthalmitis. European Society for Cataract
& Refractive Surgeons, 2007: 2.
16. Endophthalmitis Study
Group, European Society of Cataract and Refractive Surgeons. Prophylaxis of
postoperative endophthalmitis following cataract surgery: results of the ESCRS
multicenter study and identification of risk factors. J Cataract Refract Surg.
2007; 33 (6): 978–988.
17. Bowen RC, Zhou AX,
Bondalapati S, Lawyer TW, Snow KB, Evans PR et al. Comparative analysis of the safety and
efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of
cataract surgery: a meta-analysis.Br J Ophthalmol. 2018 Sep; 102 (9):
1268-1276.
18. García-Sáenz MC,
Arias-Puente A, Rodríguez-Caravaca G, Bańuelos JB. Effectiveness of
intracameral cefuroxime in preventing endophthalmitis after cataract surgery:
Ten-year comparative study. J Cataract Refract
Surg, 2010; 36 (2): 203-7.
19. Montan PG, Wejde G, Koranyi
G, Rylander M. Prophylactic intracameral cefuroxime: Efficacy in preventing
endophthalmitis after cataract surgery. Journal of Cataract Refract Surg, 2002;
28 (6): 977-81.
20. Seal DV, Barry P, Gettinby
G, Lees F, Peterson M, Revie CW et al. ESCRS study of prophylaxis of
postoperative endophthalmitis after cataract surgery: Case for a European
multi-centre study. J Cataract Refract Surg. 2006; 32: 396-406.
21. Röck T, Bramkamp M,
Bartz-Schmidt KU, Mutlu U, Yörük E, Röck D et al. Using intracameral
cefuroxime reduces postoperative endophthalmitis rate: 5 year experience at the
University Eye Hospital Tübingen. Klin Monbl Augenheilkd. 2014 Oct; 231 (10):
1023-1028.
22. Linertová R, Abreu-González
R, García-Pérez L, Alonso-Plasencia M, Cordovés-Dorta LM, Abreu-Reyes JA et al.
Intracameral cefuroxime and moxifloxacin used as endophthalmitis prophylaxis
after cataract surgery: systematic review of effectiveness and
cost-effectiveness. Clin Ophthalmol. 2014 Aug 14; 8: 1515-22.
Doi:10.2147/OPTH.S59776.
23. Sharma S, Sahu SK, Dhillon
V, Das S, Rath S. Reevaluating intracameral cefuroxime as a prophylaxis
against endophthalmitis after cataract surgery in India. J Cataract Refract
Surg. 2015 Feb; 41 (2): 393-9.
24. Grzybowski A. Has the
Time Come for All to Routinely Use Intracameral Antibiotic Prophylaxis at the
Time of Cataract Surgery? Am J Ophthalmol. 2016 Sep; 169: 293-294.
Author’s
Affiliation
Prof. Muhammad Moin
Professor of Ophthalmology
Postgraduate Medical Institute
Ameer-ud-Din Medical College
Lahore General Hospital,
Lahore
Dr. Arooj Amjad
Assistant Professor
Ophthalmology
Postgraduate Medical Institute
Ameer ud Din Medical College
Lahore General Hospital,
Lahore
Sameer Nagi
Elective Student
Lahore General Hospital,
Lahore
Final Year Medical Student
St. Georges Hospital, London,
UK
Author’s
Contribution
Prof. Muhammad Moin
Study design, Data collection,
Critical review.
Dr. Arooj Amjad
Manuscript writing and Data
analysis.
Sameer Nagi
Statistical analysis and
Manuscript writing.